胸腔镜辅助下肺癌根治术与传统开胸肺癌根治术在非小细胞肺癌患者中临床疗效的研究

Clinical Study of Thoracoscopic Assisted Radical Operation and Traditional Thoracotomy for Lung Cancer in Patients with Non-small Cell Lung Cancer

目的探究胸腔镜辅助下肺癌根治术对非小细胞肺癌患者VAS评分、出血量及临床疗效的影响。方法对2013年1月—2017年3月期间在广东省中医院接受治疗的60例非小细胞肺癌患者临床资料作研究,随机划分为2组。对照组30例,给予传统开胸手术治疗;观察组30例,给予胸腔镜辅助下肺癌根治术治疗。对2组患者VAS评分、出血量及临床疗效进行综合评价。结果观察组患者手术后1、3、5d的VAS评分均值分别为:6.26分、5.46分和4.92分,均显著低于对照组,差异有统计学意义(P<0.05);观察组患者手术时间、术中出血量、术后引流量等相关手术数据均值为:144.25min、104.35 mL和1 153.32 mL,与对照组差异有统计学意义(P<0.05);观察组治疗后有28例患者显示有效,占93.3%,显著高于对照组的63.7%,2组差异有统计学意义(P<0.05)。结论对非小细胞肺癌患者给予胸腔镜辅助下肺癌根治术治疗,能够降低患者的疼痛度,减少术中出血量,疗效显著,值得临床推广应用。

Objective This paper tries to explore the effect of thoracoscopic assisted radical operation of lung cancer on VAS score,bleeding volume and clinical efficacy in patients with non-small cell lung cancer. Methods The clinical data of 60 patients with nonsmall cell lung cancer treated in Guangdong Province Traditional Medical Hospital from January 2013 to March 2017 were selected and divided into the control group and the observation group randomly. Traditional open surgery was performed in control group. The patients in observation group underwent thoracoscopic surgery for lung cancer. The VAS score, blood loss and clinical efficacy of the two groups were evaluated comprehensively. Results The average VAS scores of the observation group at the first day, third day and fifth day after surgery were 6.26 points, 5.46 points and 4.92 points, significantly lower than those of the control group（ P〈0.05）. The data of the operative time, traoperative blood loss, postoperative drainage were 144.25 min, 104.35 mL and 1 153.32 mL（ P〈0.05）, the difference was statistically significant. 28 cases were significantly effective in the observation group, accounting for 93.3%, higher than the control group of 63.7%, the difference between the two groups was significant（P〈0.05）. Conclusion Thoracoscopic assisted radical operation of patients with non-small cell lung cancer（NSCLC） can reduce the pain and reduce the intraoperative blood loss. The curative effect is remarkable and deserves clinical application.